MicroRNA 5187 (miR-5187)

MicroRNA 5187 (miR-5187) is a small, non-coding RNA molecule in humans that acts primarily to regulate gene expression by targeting messenger RNAs (mRNAs) for degradation or translational repression, similar to other microRNAs[1][4][5]. The “hsa-” prefix designates it as a human microRNA. While the general biology of microRNAs is well-established, the specific functional, mechanistic, and clinical evidence for miR-5187 itself is extremely limited. One study identifies miR-5187-5p as a possible biomarker for unprotected left main coronary artery disease and notes possible roles in proliferation and migration in human bladder cancer, but detailed molecular targets, validated disease pathways, and drug interactions remain largely unexplored[1]. Due to the scarcity of studies and functional characterization, its role as a direct therapeutic target is not established, and its annotation may be incomplete or tentative.\n\nKey points and issues:\n- Although miR-5187-5p has been described in the medical literature, evidence for it as a bona fide, functionally validated therapeutic target is currently lacking. Its annotation and characterization may be incomplete or based only on limited sequencing/biomarker screens[1].\n- No specific drugs, inhibitors, or targeted interventions are currently linked to miR-5187.\n- Like other microRNAs, it is classified as a non-coding RNA rather than a classical therapeutic target such as receptor, enzyme, or transporter.\n- Given the absence of substantial mechanistic, biomarker, or therapeutic data, there is a high likelihood this target is incompletely characterized or may reflect a provisional or less well-studied microRNA sequence, and should be flagged for caution in structured databases.

Other names

hsa-mir-5187mir-5187MIR5187